Transition Considerations For Congenital Adrenal Hyperplasia
Published 2019 · Medicine
Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is a condition in which there is a defect in adrenal steroidogenesis leading to defective cortisol production, salt wasting, and varying degrees of hyperandrogenism. This lifelong endocrine condition requires multiple medications, frequent laboratory evaluation, and close monitoring to prevent adverse long-term outcomes. The management of CAH can be challenging, especially during the transition from pediatric to adult care. During adolescence, specific treatment and educational topics for patients and families must be addressed by the medical team to help prepare for managing CAH in adulthood. The aim of this chapter is to discuss management goals in the adolescent period, psychosocial and educational issues specific to CAH that should be addressed with patients and families, and appropriate transition practices from pediatric to adult care.